BRAINLIFE.ORG





Topics


Glioblastoma | Treatment | Targeted therapy | Afatinib






Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Afatinib






Gettinger SN, Song Z, Reckamp KL, Moscow JA, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton DR, Williams PM, Hamilton SR, Kong XT, Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT.
Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A.
JCO Precis Oncol. 2024 Jul 10;8:e2300725. doi: 10.1200/PO.23.00725. PMID: 38986051. Interventional study˰ ˍ